Genetics and therapy type determine second cancer risk after childhood treatment

Physicians caring for survivors of childhood cancer later in life should be aware that survivors’ genetics, in addition to their lifesaving cancer treatment, contribute to the risk for secondary cancers. This finding comes from scientists at St. Jude Children’s Research Hospital who quantified different factors’ contributions to the risk of a second cancer, the primary cause of mortality for long-term survivors. The new research used data from the St. Jude Lifetime Cohort Study (St. Jude…

Continue Reading


News Source: www.sciencedaily.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *